These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7736302)

  • 21. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Implantable cardioverter-defibrillator].
    Fuhrer J
    Praxis (Bern 1994); 1996 May; 85(20):655-62. PubMed ID: 8685557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different ways of application of the implantable cardioverter defibrillator (ICD)--which is the current approach?
    Herse B; Autschbach R; Hannekum A; Dalichau H; Gonska B
    Thorac Cardiovasc Surg; 1992 Oct; 40(5):266-72. PubMed ID: 1485315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with the implantable cardioverter defibrillator (ICD)].
    Jordaens LJ
    Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from the failure and recall of an implantable cardioverter-defibrillator.
    Hauser RG; Maron BJ
    Circulation; 2005 Sep; 112(13):2040-2. PubMed ID: 16172264
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?].
    Oreziak A; Przybylski A
    Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introduction to the automatic implantable cardioverter-defibrillator and its anesthetic implications.
    Likens ML
    AANA J; 1993 Aug; 61(4):388-93. PubMed ID: 8379287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of the implantable cardioverter-defibrillator.
    Epstein AE
    J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
    Thakor NV; Natarajan A
    Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.